HLA Antigens

"HLA Antigens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases.

Descriptor ID	D006680
MeSH Number(s)	D23.050.301.500.450 D23.050.705.552.450
Concept/Terms	HLA Antigens HLA Antigens Antigens, HLA HL-A Antigens Antigens, HL-A HL A Antigens Human Leukocyte Antigens Antigens, Human Leukocyte Leukocyte Antigens, Human Leukocyte Antigens Antigens, Leukocyte

Below are MeSH descriptors whose meaning is more general than "HLA Antigens".

Chemicals and Drugs [D]
Biological Factors [D23]
Antigens [D23.050]
Antigens, Surface [D23.050.301]
Histocompatibility Antigens [D23.050.301.500]
HLA Antigens [D23.050.301.500.450]
Isoantigens [D23.050.705]
Histocompatibility Antigens [D23.050.705.552]
HLA Antigens [D23.050.705.552.450]

Below are MeSH descriptors whose meaning is related to "HLA Antigens".

Below are MeSH descriptors whose meaning is more specific than "HLA Antigens".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "HLA Antigens" by people in this website by year, and whether "HLA Antigens" was a major or minor topic of these publications.

Bar chart showing 86 publications over 28 distinct years, with a maximum of 10 publications in 2021

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	1	2	3
1997	3	2	5
1998	1	0	1
1999	1	0	1
2000	1	4	5
2001	1	0	1
2002	1	0	1
2003	1	0	1
2004	2	0	2
2005	1	2	3
2006	0	2	2
2007	3	1	4
2008	0	1	1
2009	3	0	3
2010	0	4	4
2011	0	1	1
2013	1	1	2
2014	3	0	3
2015	3	3	6
2016	3	2	5
2017	2	3	5
2018	2	1	3
2019	0	4	4
2020	2	4	6
2021	5	5	10
2022	1	0	1
2023	1	1	2
2024	0	1	1

Below are the most recent publications written about "HLA Antigens" by people in Profiles.

Gamero MT, Uber P, Brailovsky Y, Gibson G, Rame E, Alvarez R, Huang Y, Rajapreyar I. The dilemma of the role of the non-HLA antibodies in AMR. Clin Transplant. 2024 03; 38(3):e15274.

View in: PubMed
Long JJ, Motter JD, Jackson KR, Chen J, Orandi BJ, Montgomery RA, Stegall MD, Jordan SC, Benedetti E, Dunn TB, Ratner LE, Kapur S, Pelletier RP, Roberts JP, Melcher ML, Singh P, Sudan DL, Posner MP, El-Amm JM, Shapiro R, Cooper M, Verbesey JE, Lipkowitz GS, Rees MA, Marsh CL, Sankari BR, Gerber DA, Wellen JR, Bozorgzadeh A, Gaber AO, Heher EC, Weng FL, Djamali A, Helderman JH, Concepcion BP, Brayman KL, Oberholzer J, Kozlowski T, Covarrubias K, Massie AB, McAdams-DeMarco MA, Segev DL, Garonzik-Wang JM. Characterizing the risk of human leukocyte antigen-incompatible living donor kidney transplantation in older recipients. Am J Transplant. 2023 12; 23(12):1980-1989.

View in: PubMed
Ravindranath MH, Ravindranath NM, Selvan SR, Hilali FE, Amato-Menker CJ, Filippone EJ. Cell Surface B2m-Free Human Leukocyte Antigen (HLA) Monomers and Dimers: Are They Neo-HLA Class and Proto-HLA? Biomolecules. 2023 07 28; 13(8).

View in: PubMed
File B, Huang Y, Peedin A, Gergis U. The impact of HLA donor-specific antibodies on engraftment and the evolving desensitization strategies. Bone Marrow Transplant. 2022 04; 57(4):526-531.

View in: PubMed
Song IH, Kim YA, Heo SH, Bang WS, Park HS, Choi YH, Lee H, Seo JH, Cho Y, Jung SW, Kim HJ, Ahn SH, Lee HJ, Gong G. The Association of Estrogen Receptor Activity, Interferon Signaling, and MHC Class I Expression in Breast Cancer. Cancer Res Treat. 2022 Oct; 54(4):1111-1120.

View in: PubMed
Alzahrani M, Damlaj M, Essa M, Alahmari B, Alaskar A, Hejazi A, Basher E, Alsadi H, Ahmed M, Abujoub R, Ghazi S, Alshobaki H, Abuelgasim K, Salama H, Gmati G, Alsultan A. HLA-identical related hematopoietic stem cell transplantation in severe sickle cell disease: age is not a barrier to successful outcome. Bone Marrow Transplant. 2022 02; 57(2):292-294.

View in: PubMed
Yarmarkovich M, Marshall QF, Warrington JM, Premaratne R, Farrel A, Groff D, Li W, di Marco M, Runbeck E, Truong H, Toor JS, Tripathi S, Nguyen S, Shen H, Noel T, Church NL, Weiner A, Kendsersky N, Martinez D, Weisberg R, Christie M, Eisenlohr L, Bosse KR, Dimitrov DS, Stevanovic S, Sgourakis NG, Kiefel BR, Maris JM. Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARs. Nature. 2021 11; 599(7885):477-484.

View in: PubMed
Filippone EJ, Farber JL. Histologic Antibody-mediated Kidney Allograft Rejection in the Absence of Donor-specific HLA Antibodies. Transplantation. 2021 11 01; 105(11):e181-e190.

View in: PubMed
Filippone EJ, Gulati R, Farber JL. Noninvasive Assessment of the Alloimmune Response in Kidney Transplantation. Adv Chronic Kidney Dis. 2021 11; 28(6):548-560.

View in: PubMed
Ravindranath MH, Filippone EJ, Amato-Menker CJ, Arosa FA, Das B, Ou Y, Norin AJ. Antibodies to cryptic epitopes on HLA class I and class II heavy chains bound to single antigen beads: Clinically relevant? Transpl Immunol. 2021 12; 69:101482.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement